LAX.SH
CARE RATINGS LIMITED·RATING AGENCIES 49.67·Capital Markets Companies
Price
1,674.4
-1.45%52W Range
Market Cap
₹5,031.43 Cr
Traded: ₹11.26 Cr (0.22%) 0.0x
Free Float: ₹1,623.64 Cr (0.69% of FF traded)
Volume · 60D trend
66.23 K 0.0x
Delivery: % 0.0x
View Delivery Data
Returns
Valuation
Business Strength
Growth (3Y CAGR)
Balance Sheet
Cash Position
Others
MTF Exposure Trend
60 sessions · funded amount, % of FF, daily delta
LAX.SH
Growth Trends
| Metric | 10Y | 5Y | 3Y | 1Y | TTM | Trend |
|---|---|---|---|---|---|---|
| Sales | +5.0% | +14.0% | +19.0% | -- | +18.0% | Stable |
| ROE | +19.0% | +16.0% | +18.0% | -- | -- | Stable |
| Return | +4.0% | +20.0% | +34.0% | +7.0% | -- | Stable |
| Profit | +4.0% | +14.0% | +27.0% | -- | +25.0% | Stable |
Quarterly Results
Mar 2023
Dec 2022
Sep 2022
Revenue & Margin Trends
Annual
Quarterly
Balance Sheet Health
Leverage
Efficiency
Cash Position
Detailed Financials
Jun 2026PDF ↗ | Mar 2026PDF ↗ | Dec 2025PDF ↗ | Sep 2025PDF ↗ | Jun 2025PDF ↗ | Mar 2025PDF ↗ | Dec 2024PDF ↗ | Sep 2024PDF ↗ | Jun 2024PDF ↗ | Mar 2024PDF ↗ | Dec 2023PDF ↗ | Sep 2023PDF ↗ | Jun 2023PDF ↗ | Mar 2023 | Dec 2022 | Sep 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 112 | 131 | 112 | 136 | 94 | 110 | 96 | 117 | 79 | 90 | 79 | 96 | 66 | 78 | 62 | 85 |
| Expenses | 77 | 70 | 72 | 68 | 66 | 62 | 66 | 62 | 57 | 61 | 55 | 55 | 49 | 50 | 48 | 43 |
| Operating Profit | 35 | 61 | 40 | 68 | 28 | 47 | 30 | 56 | 22 | 29 | 23 | 42 | 18 | 27 | 14 | 42 |
| OPM % | 31.0% | 46.0% | 36.0% | 50.0% | 30.0% | 43.0% | 32.0% | 47.0% | 28.0% | 32.0% | 30.0% | 43.0% | 27.0% | 35.0% | 22.0% | 50.0% |
| Other Income | 15 | 16 | 13 | 13 | 14 | 15 | 12 | 12 | 12 | 10 | 14 | 11 | 12 | 10 | 12 | 8 |
| Interest | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 |
| Depreciation | 4 | 4 | 4 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 |
| Profit Before Tax | 45 | 72 | 49 | 77 | 37 | 59 | 39 | 64 | 30 | 36 | 34 | 50 | 26 | 34 | 23 | 48 |
| Tax % | 27.0% | 26.0% | 25.0% | 26.0% | 29.0% | 26.0% | 27.0% | 27.0% | 30.0% | 32.0% | 30.0% | 29.0% | 31.0% | 41.0% | 28.0% | 27.0% |
| Net Profit | 33 | 53 | 37 | 57 | 26 | 43 | 28 | 47 | 21 | 25 | 24 | 36 | 18 | 20 | 16 | 35 |
| Exceptional Items | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| EPS (Rs) | 10.7 | 17.6 | 12.0 | 18.9 | 8.6 | 14.2 | 9.3 | 15.4 | 6.9 | 8.1 | 7.9 | 11.8 | 6.0 | 6.6 | 5.4 | 11.6 |
| Sales Growth (YoY) | -- | 19.2% | 16.3% | 16.2% | 19.0% | 21.6% | 22.5% | 21.7% | 18.8% | 16.3% | 26.6% | 13.8% | 21.7% | 17.6% | -- | -- |
| Sales Growth (QoQ) | -- | 17.0% | -17.6% | 44.7% | -14.6% | 14.6% | -17.9% | 48.1% | -12.2% | 13.9% | -17.7% | 45.5% | -15.4% | 25.8% | -27.1% | -- |
| OP Growth (YoY) | 25.0% | 29.8% | 33.3% | 21.4% | 27.3% | 62.1% | 30.4% | 33.3% | 22.2% | 7.4% | 64.3% | 0.0% | -- | -- | -- | -- |
| OP Growth (QoQ) | -42.6% | 52.5% | -41.2% | 142.9% | -40.4% | 56.7% | -46.4% | 154.5% | -24.1% | 26.1% | -45.2% | 133.3% | -33.3% | 92.9% | -66.7% | -- |
| Profit Growth (YoY) | -- | 24.0% | 29.0% | 23.0% | 24.0% | 77.0% | 18.0% | 31.0% | 16.0% | 23.0% | 47.0% | 3.0% | 30.0% | -14.0% | 9.6% | 29.0% |
| EPS Growth (YoY) | -- | 23.5% | 28.7% | 22.6% | 24.1% | 76.5% | 17.9% | 30.5% | 15.9% | 22.3% | 46.5% | 2.1% | -- | -- | -- | -- |
| EPS Growth (QoQ) | -- | 47.0% | -36.7% | 119.4% | -39.5% | 53.3% | -39.7% | 122.0% | -14.0% | 2.4% | -33.3% | 97.2% | -9.2% | 22.7% | -53.5% | -- |
| OP Margin | -- | 46.6% | 35.7% | 50.0% | 29.8% | 42.7% | 31.3% | 47.9% | 27.9% | 32.2% | 29.1% | 43.8% | 27.3% | 34.6% | 22.6% | 49.4% |
| Net Margin | -- | 40.5% | 33.0% | 41.9% | 27.7% | 39.1% | 29.2% | 40.2% | 26.6% | 27.8% | 30.4% | 37.5% | 27.3% | 25.6% | 25.8% | 41.2% |
| Material Cost % | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Employee Cost % | 53.0% | 40.0% | 49.0% | 39.0% | 57.0% | 43.0% | 52.0% | 39.0% | 58.0% | 48.0% | 54.0% | 42.0% | 58.0% | 48.0% | 54.6% | 40.1% |
| P/S | 10.25 | 11.11 | 10.69 | 11.10 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| P/E | 28.30 | 30.67 | 29.95 | 31.60 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| P/B | 5.40 | 5.64 | 5.61 | 5.62 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
Exchange Filings
50Intimation of Reschedule of Investor Meet
Intimation of Investor Meet
Intimation of Investor Meet
Intimation of Investor Meet
Intimation of Investor Meet
Newspaper Advertisement for publication for Financial Results
Outcome of the meeting of the Board of Directors of CARE Ratings Limited held on August 7, 2026
Intimation of Investor Meet
Press Release and Investor Presentation for the quarter ended June 30, 2026
Press Release and Investor Presentation for the quarter ended June 30, 2026
Outcome of the meeting of the Board of Directors of CARE Ratings Limited held on August 7, 2026
Certificate under Reg 74(5) of SEBI (DP) Regulations, 2018
Certificate under Reg 74(5) of SEBI (DP) Regulations, 2018
Allotment of 26,733 equity shares pursuant to exercise of ESOP
Summary of Proceedings of the 33rd AGM of the Company
Scrutinizer''s Report along with Voting Results of 33rd AGM
Re-appointment of B S R & Co. LLP, Chartered Accountants as Statutory Auditor
Disclosure under Regulation 30 of the SEBI (LODR) Regulations, 2015
Closure of Trading Window
Reschedule of Investor Meet
Intimation of Investor Meet
Intimation of Investor Meet
Allotment of 11,250 equity shares pursuant to exercise of ESOP
Newspaper Publication
Annual General Meeting to be held on July 03 2026
Letters send to Shareholders
IEPF Newspaper Publication
Annual Report FY26
Pre-AGM Newspaper Publication
Intimation of Investor Meet
Intimation for Investors Meet
Transcript of the Earnings Conference Call held on May 14,2026
Newspaper Advertisement for publication of Financial Results of the Company for the quarter and year ended March 31, 2026.
Intimation of Investor Meet
Audio recording of Earnings Conference Call for the Quarter and Year Ended March 31, 2026
Outcome of Board Meeting
Grant of ESOPs to eligible employees
Financial Results for quarter and financials year ended March 31, 2026
Declared Final Dividend of Rs. 14/- per share
Press Release and Investor Presentation
Corporate Action - Record date for final dividend
Annual General Meeting on July 3, 2026
Re-appointment of Statutory Auditors subject to approval of Shareholders at ensuing Annual General Meeting
Investor Presentation
Details of Earnings Call
NSE-CareEdge Ratings commercially launches PaRRVA, a standard framework for investment performance verification
Allotment of equity shares pursuant to exercise of ESOP and Grant of Stock Options under CARE Employee Stock Option Scheme 2020
Grant of Stock Options
Intimation pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
CARE Ratings Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/05/2026 ,inter alia, to consider and approve the Audited (Standalone & Consolidated) ....
Annual Reports
15Concalls
52Feb 2026
28 Feb 2026Nov 2025
30 Nov 2025Aug 2025
31 Aug 2025May 2025
31 May 2025Jan 2025
31 Jan 2025Oct 2024
31 Oct 2024Aug 2024
31 Aug 2024May 2024
31 May 2024Jan 2024
31 Jan 2024Oct 2023
31 Oct 2023Aug 2023
31 Aug 2023Aug 2023
31 Aug 2023May 2023
31 May 2023May 2023
31 May 2023Jan 2023
31 Jan 2023Jan 2023
31 Jan 2023Nov 2022
30 Nov 2022Nov 2022
30 Nov 2022Jul 2022
31 Jul 2022Jul 2022
31 Jul 2022May 2022
31 May 2022May 2022
31 May 2022Feb 2022
28 Feb 2022Nov 2021
30 Nov 2021Aug 2021
31 Aug 2021Aug 2021
31 Aug 2021Aug 2021
31 Aug 2021Jun 2021
30 Jun 2021Feb 2021
28 Feb 2021Nov 2020
30 Nov 2020Aug 2020
31 Aug 2020Jun 2020
30 Jun 2020Jun 2020
30 Jun 2020Feb 2020
29 Feb 2020Nov 2019
30 Nov 2019Nov 2019
30 Nov 2019Aug 2019
31 Aug 2019Jun 2019
30 Jun 2019May 2019
31 May 2019Feb 2019
28 Feb 2019May 2018
31 May 2018May 2018
31 May 2018Jan 2018
31 Jan 2018Jan 2018
31 Jan 2018Nov 2017
30 Nov 2017Aug 2017
31 Aug 2017May 2017
31 May 2017Feb 2017
28 Feb 2017May 2016
31 May 2016Feb 2016
29 Feb 2016Nov 2015
30 Nov 2015Jul 2015
31 Jul 2015Held by Mutual Funds
26 schemes hold carerating · sorted by weight